Back
Vista Gold Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
52
VGZ
Vista Gold
Last Price:
0.71
Seasonality Move:
-11.7%
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
49.55
Seasonality Move:
5.37%
Buy
52
Vista Gold (VGZ)
is a Buy
Is Vista Gold a Buy, Sell or Hold?
- The current Vista Gold [VGZ] share price is $0.66. The Score for VGZ is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- VGZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $49.30. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VGZ Stock Price Chart
What is Vista Gold's stock price today?
-
The Vista Gold share price today is $0.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VGZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $49.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
VGZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 64.2 | Buy |
| Chaikin Money Flow: | 674821 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.64) | Buy |
| Bollinger Bands (100): | (0.48 - 0.58) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 56.64 | Buy |
| Chaikin Money Flow: | 166831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.27 - 48.71) | Buy |
| Bollinger Bands (100): | (39.16 - 47.88) | Buy |
VGZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Buy |
| 20-day SMA: | 0.61 | Buy |
| 50-day SMA: | 0.55 | Buy |
| 200-day SMA: | 0.48 | Buy |
| 8-day EMA: | 0.62 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.56 | Buy |
| 200-day EMA: | 0.51 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.6 | Buy |
| 20-day SMA: | 47.36 | Buy |
| 50-day SMA: | 47.18 | Buy |
| 200-day SMA: | 43.02 | Buy |
| 8-day EMA: | 48.76 | Buy |
| 20-day EMA: | 47.77 | Buy |
| 50-day EMA: | 46.41 | Buy |
| 200-day EMA: | 41.1 | Buy |
Vista Gold Earnings Growth & VGZ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.15 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
Vista Gold Technical Analysis
| Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||